Warning letter
Community Blood Centers of Florida, Inc.: warning letter of Apr 27, 2012
FDA warning letter UCM313460 · Florida District Office
Key facts
| Reference number | UCM313460 |
|---|---|
| Company | Community Blood Centers of Florida, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Apr 27, 2012 |
| Posted date | Apr 27, 2012 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 211, 211.22, 606.160, 606.100(c), 606.160(b)(1)(vii), 606.165(b), 640.11(a), 606.65, 610.40(a), 610.46(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: